FINHUB Insights

IQV · Q1 FY25 · Jan 1 – Mar 31, 2025

IQVIA Q1 FY25: where the revenue came from and where it went

IQVIA Q1 FY25: revenue $3.8B (+2% year over year). Net profit $0.2B. Largest cohort Research and Development $2.1B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jan 1 – Mar 31, 2025
Reported
May 6, 2025 10-Q
Sankey diagram of IQVIA's income statement for Q1 FY25: revenue of $3.8 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$3.8B +2% year over year
Gross profit$1.3B 34% margin
Operating profit$0.5B 13% margin
Net profit$0.2B 7% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY25 (period ends Mar 31, 2025).
ItemValueShare of revenueYear over year
Revenue 3.8 100% +2%
Research and Development 2.1 55% +0%
Technology and Analytics 1.5 39% +6%
Contract Sales and Medical 0.2 5% −4%
Cost of revenue−2.566%
Gross profit1.334% margin+12pp
SG&A−0.513%+0pp
Other−0.38%+0pp
Operating profit0.513% margin−1pp
Tax−0.1
Interest & other costs−0.2
Net profit0.27%−1pp
Filing on EDGAR More quarters of IQV

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters